Agreed, reads better to me a lay person and provides greater confidence in the drug’s value proposition and hence future adoption.
Given that we are already at AUD $756 Mn (about USD$500 Mn) is the potential upside including acquisition multiple max of 10X of current MC?
Ann: Additional COBRA trial data results, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.03 |
Change
-0.270(4.29%) |
Mkt cap ! $1.899B | |||
| Open | High | Low | Value | Volume |
| $6.30 | $6.45 | $5.65 | $13.43M | 2.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14784 | $5.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.04 | 4000 | 2 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |